Ken Griffin Shockwave Medical, Inc. Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Shockwave Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 31,800 shares of SWAV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,800

Previous 42,500 25.18%

Holding current value

Previous $8.1 Million 27.87%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $75.5 Million - $129 Million	-395,062 Reduced 44.37%	495,358 $161 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $84.1 Million - $113 Million	522,447 Added 141.98%	890,420 $170 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $62.5 Million - $91.3 Million	321,500 Added 691.8%	367,973 $73.3 Million
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $25.7 Million - $34.9 Million	-115,306 Reduced 71.27%	46,473 $13.3 Million
Q1 2023 May 15, 2023	SELL	$175.41 - $217.92 $3.86 Million - $4.79 Million	-21,993 Reduced 11.97%	161,779 $35.1 Million

Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $16.5 Million - $23.9 Million	80,540 Added 78.02%	183,772 $37.8 Million
Q3 2022 Nov 14, 2022	BUY	$195.21 - $310.53 $20.2 Million - $32.1 Million	103,232 New	103,232 $28.7 Million
Q1 2022 May 16, 2022	SELL	$127.96 - $207.36 $4.77 Million - $7.73 Million	-37,289 Reduced 43.46%	48,505 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$165.13 - $241.83 $8.21 Million - $12 Million	49,723 Added 137.85%	85,794 $15.3 Million
Q3 2021 Nov 15, 2021	SELL	$163.99 - $235.57 $8.3 Million - $11.9 Million	-50,608 Reduced 58.39%	36,071 $7.43 Million
Q2 2021 Aug 16, 2021	SELL	$131.45 - $201.49 $3.58 Million - $5.49 Million	-27,264 Reduced 23.93%	86,679 $16.4 Million
Q1 2021 May 17, 2021	BUY	$92.73 - $142.05 $3.32 Million - $5.09 Million	35,836 Added 45.88%	113,943 $14.8 Million
Q4 2020 Feb 16, 2021	SELL	$67.44 - $103.72 $5.22 Million - $8.03 Million	-77,451 Reduced 49.79%	78,107 $8.1 Million
Q3 2020 Nov 16, 2020	SELL	$42.79 - $75.8 $14.4 Million - $25.5 Million	-336,192 Reduced 68.37%	155,558 $11.8 Million
Q2 2020 Aug 14, 2020	SELL	$27.25 - $47.53 $5.03 Million - $8.77 Million	-184,582 Reduced 27.29%	491,750 $23.3 Million
Q1 2020 May 15, 2020	BUY	$23.16 - $47.74 $9.08 Million - $18.7 Million	392,183 Added 138.02%	676,332 $22.4 Million
Q4 2019 Feb 14, 2020	BUY	$29.4 - $44.98 $3.32 Million - $5.08 Million	112,878 Added 65.91%	284,149 $12.5 Million
Q3 2019 Nov 14, 2019	BUY	$29.71 - $55.23 $4.33 Million - $8.05 Million	145,771 Added 571.65%	171,271 $5.13 Million
Q2 2019 Aug 14, 2019	SELL	$29.73 - $66.02 $6.9 Million - $15.3 Million	-232,117 Reduced 90.1%	25,500 $1.46 Million
Q1 2019 May 15, 2019	BUY	$29.41 - $38.1 $7.58 Million - $9.82 Million	257,617 New	257,617 $0

Others Institutions Holding SWAV

# of Institutions

532

Shares Held

33.4M

Call Options Held

521K

Put Options Held

518K

View Full List

About Shockwave Medical, Inc.

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

More about SWAV

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account